Summary |
|
|||||||||||||
Variant origin |
|
|||||||||||||
Variant description |
|
|||||||||||||
Phenotypes |
View phenotypes and curated references for all genotypes (concatenated display).
|
|||||||||||||
Expression |
|
|||||||||||||
Notes |
Mapping and Phenotype information for this QTL, its variants and associated markersJ:76105100 microsatellite markers at an average spacing of 15 cM were screened in 70 (C57BL/6J x DBA/2J-Tg(Myhca-Casq2)1Mord)F1 x C57BL/6J backcross animals and 50 (C57BL/6J x DBA/2J-Tg(Myhca-Casq2)1Mord)F1 x DBA/2J backcross animals to identify QTLs associatedwith cardiac function and survival. (C57BL/6J x DBA/2J-Tg(Myhca-Casq2)1Mord)F1 hybrid mice show markedly decreased survival and heart function compared to parental DBA/2J-Tg(Myhca-Casq2)1Mord mice. In the first backcross, a QTL linked to heart failure,Hrtfm1, mapped to mouse chromosome 2 at 40.4 cM with a peak LOD=7.8 at D2Mit327. The QTL range of Hrtfm1 spans 38.3 cM - 43.5 cM. Haplotype analysis further refined interval to a 1.1 cM region between D2Mit325 and D2Mit418. DBA/2J-derived alleles confer increased survival at Hrtfm1 with a dominant mode of inheritance. A possible candidate gene for Hrtfm1 is titin (Ttn). In the second backcross, a QTL linked to both cardiac function and survival, Hrtfm2, mapped to 76.2 cM on mouse Chromosome 3 with a peak LOD=9.3 at D3Mit86. The QTL range of Hrtfm2 spans 71.8 cM - 72.9 cM. Haplotype analysis further refined the interval to a 5.2 cM region between D3Mit320 and D3Mit260. C57BL/6J-derived alleles confer decreased heart function and survival at Hrtfm2 with adominant mode of inheritance. |
|||||||||||||
References |
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/10/2024 MGI 6.24 |
|
|